Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 41, 2019 - Issue 4
Submit an article Journal homepage
228
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

T cells expressing CD26-specific chimeric antigen receptors exhibit extensive self-antigen-driven fratricide

Shu ZhouInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; View further author information
,
Xiaoying ZhuInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; View further author information
,
Na ShenInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; View further author information
,
Qing LiDepartment of Hematology, Wuhan No. 1 Hospital, Wuhan, China; View further author information
,
Na WangDepartment of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Yong YouInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; View further author information
,
Zhaodong ZhongInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; View further author information
,
Fanjun ChengInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; View further author information
,
Ping ZouInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; View further author information
&
Xiaojian ZhuDepartment of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 490-496 | Received 07 Feb 2019, Accepted 26 Jun 2019, Published online: 15 Jul 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xiaoying Zhu, Zhaodong Zhong, Fankai Meng, Ping Zou, Yong You, Qing Li & Xiaojian Zhu. (2023) CD26 CAR-T cells have attenuated mitochondrial and glycolytic metabolic profiling. Immunopharmacology and Immunotoxicology 45:6, pages 709-718.
Read now

Articles from other publishers (8)

Eiji Kobayashi, Yusuke Kamihara, Miho Arai, Akinori Wada, Shohei Kikuchi, Ryo Hatano, Noriaki Iwao, Takeshi Susukida, Tatsuhiko Ozawa, Yuichi Adachi, Hiroyuki Kishi, Nam H. Dang, Taketo Yamada, Yoshihiro Hayakawa, Chikao Morimoto & Tsutomu Sato. (2023) Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies. Cells 12:16, pages 2059.
Crossref
Jiali Cheng, Yuyan Zhao, Hui Hu, Ling Tang, Yuhao Zeng, Xinyue Deng, Shengnan Ding, An-Yuan Guo, Qing Li & Xiaojian Zhu. (2023) Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics. Cancer Immunology, Immunotherapy.
Crossref
Stephanie Sembill, Maria Ampatzidou, Sonali Chaudhury, Michael Dworzak, Krzysztof Kalwak, Axel Karow, Alexander Kiani, Manuela Krumbholz, Maaike Luesink, Nora Naumann-Bartsch, Barbara De Moerloose, Michael Osborn, Kirk R. Schultz, Petr Sedlacek, Fiorina Giona, Christian Michel Zwaan, Hiroyuki Shimada, Birgitta Versluijs, Frederic Millot, Nobuko Hijiya, Meinolf Suttorp & Markus Metzler. (2023) Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations. Leukemia 37:3, pages 505-517.
Crossref
Ling Tang, Hongming Huang, Yutong Tang, Qing Li, Jue Wang, Dengju Li, Zhaodong Zhong, Ping Zou, Yong You, Yang Cao, Yingjie Kong, Anyuan Guo, Shu Zhou, Huimin Li, Fankai Meng, Yi Xiao & Xiaojian Zhu. (2022) CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations. Clinical and Translational Medicine 12:9.
Crossref
Emile Verhulst, Delphine Garnier, Ingrid De Meester & Brigitte Bauvois. (2022) Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?. Cancers 14:3, pages 624.
Crossref
Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani & Fatemeh Rahbarizadeh. (2021) Novel antigens of CAR T cell therapy: New roads; old destination. Translational Oncology 14:7, pages 101079.
Crossref
Martijn P.T. Ernst, Mike Broeders, Pablo Herrero-Hernandez, Esmee Oussoren, Ans T. van der Ploeg & W.W.M. Pim Pijnappel. (2020) Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease. Molecular Therapy - Methods & Clinical Development 18, pages 532-557.
Crossref
Yadi Han, Yuxue Sun, Yusong Zhang & Qingxin Xia. (2020) High DPP4 expression predicts poor prognosis in patients with low-grade glioma. Molecular Biology Reports 47:3, pages 2189-2196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.